NEW MEDICINES LISTED ON THE PBS

Australians suffering from melanoma and multiple sclerosis have new treatment options, with new and amended PBS listings. 🔸 Tafinlar® (dabrafenib) and Mekinist® (trametinib) will be extended to include subsidy for post-surgery treatment for patients who have Stages IIIB, IIIC and IIID…

Read more

$27 million for new PBS medicines

The Government will invest $27 million to provide affordable access to three new medicines through the Pharmaceutical Benefits Scheme (PBS), helping Australians living with complications following stroke, fighting cancer, and experiencing syphilis in northern, central and southern Australia. The September…

Read more